Results of liver biopsy and long term course in HBsAg patients immunotolerant for HBV

被引:0
|
作者
Mohand, D [1 ]
Serfaty, L [1 ]
Chazouillère, O [1 ]
Poupon, R [1 ]
Andreani, T [1 ]
机构
[1] Hop St Antoine, Dept Hepatol, F-75571 Paris, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
518
引用
收藏
页码:187 / 187
页数:1
相关论文
共 50 条
  • [1] HBV INFECTION AFTER LIVER-TRANSPLANTATION IN HBSAG POSITIVE PATIENTS - EXPERIENCE WITH LONG-TERM IMMUNOPROPHYLAXIS
    SAMUEL, D
    BISMUTH, A
    SERRES, C
    ARULNADEN, JL
    REYNES, M
    BENHAMOU, JP
    BRECHOT, C
    BISMUTH, H
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1492 - 1494
  • [2] Is it possible to reduce liver biopsy indication in HBsAg positive patients with undetectable serum HBV-DNA?
    Tainturier-Sayeg, MH
    Ratziu, V
    Thibault, V
    Bonyhay, L
    Charlotte, F
    Benhamou, Y
    Opolon, P
    Poynard, T
    HEPATOLOGY, 2000, 32 (04) : 452A - 452A
  • [3] Prevention of HBV Recurrence After Liver Transplant: Long-Term Results
    Chang, Seong-Hwan
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (05) : 1707 - 1710
  • [4] Long-term presence of HBV in the sera of chronic hepatitis B patients with HBsAg seroclearance
    Arase, Yasuji
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Kobayashi, Masahiro
    Akuta, Norio
    Someya, Takashi
    Hosaka, Tetsuya
    Sezaki, Hitomi
    Sato, Junko
    Kobayashi, Mariko
    Ikeda, Kenji
    Kumada, Hiromitsu
    INTERVIROLOGY, 2007, 50 (03) : 161 - 165
  • [5] Distribution of HBV DNA and HBsAg in the liver of patients with liver cirrhosis and its significance
    张晓东
    王文亮
    刘彦仿
    王伯沄
    Journal of Medical Colleges of PLA, 1992, (02) : 136 - 140
  • [6] HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy
    Di Marco, V
    Di Stefano, R
    Ferraro, D
    Almasio, PL
    Bonura, C
    Giglio, M
    Parisi, P
    Cappello, M
    Alaimo, G
    Craxi, A
    ANTIVIRAL THERAPY, 2005, 10 (03) : 431 - 439
  • [7] LONG-TERM RESULTS OF HBV AND HCV INFECTION IN PATIENTS WITH BLOOD DISEASES
    Garmaeva, T. Ts.
    Kulikov, S. M.
    Mikhailova, E. A.
    Gemdzhyan, E. G.
    Gaponova, T. V.
    Grumbkova, L. O.
    Yaroslavtseva, N. G.
    Tupoleva, T. A.
    Somova, A. V.
    Makarik, T. A.
    Glinschikova, O. A.
    Fevraleva, I. S.
    Sudarikov, A. B.
    Filatov, F. P.
    Savchenko, V. G.
    TERAPEVTICHESKII ARKHIV, 2011, 83 (07) : 17 - 26
  • [8] LIVER-TRANSPLANTATION IN HBSAG-PATIENTS WITH SHORT AND LONG-TERM IMMUNOPROPHYLAXIS
    NEUHAUS, P
    BLUMHARDT, G
    BECHSTEIN, W
    KECK, H
    LEMMENS, P
    HOPF, U
    HEPATOLOGY, 1993, 18 (04) : A58 - A58
  • [9] LONG TERM HBsAg REDUCTION BY A NASAL ADMINISTRATIVE THERAPEUTIC VACCINE CONTAINING HBsAg AND HBCAG MIXED WITH MUCOADHESIVE CVP IN PATIENTS WITH CHRONIC HBV INFECTION: THE RESULTS OF 48 MONTHS FOLLOW UP
    Yoshida, Osamu
    Shiraishi, Kana
    Imai, Yusuke
    Sanada, Takahiro
    Tsukiyama-Kohara, Kyoko
    Miyazaki, Takashi
    Kamishita, Taizo
    Miyake, Teruki
    Tokumoto, Yoshio
    Aguilar, Julio Cesar
    Enrique Guillen, Gerardo
    Kohara, Michinori
    Hiasa, Yoichi
    HEPATOLOGY, 2023, 78 : S56 - S57
  • [10] Need to Strictly Define Hepatitis B Virus Immunotolerant Patients to Avoid Unnecessary Liver Biopsy
    Andreani, Tony
    Serfaty, Lawrence
    Poupon, Raoul
    Chazouilleres, Olivier
    GASTROENTEROLOGY, 2008, 135 (06) : 2155 - 2156